151 related articles for article (PubMed ID: 6180687)
21. Exploring the mango-poison ivy connection: the riddle of discriminative plant dermatitis.
Hershko K; Weinberg I; Ingber A
Contact Dermatitis; 2005 Jan; 52(1):3-5. PubMed ID: 15701120
[TBL] [Abstract][Full Text] [Related]
22. Assessment of the ability of the topical skin protectant (TSP) to protect against contact dermatitis to urushiol (Rhus) antigen.
Vidmar DA; Iwane MK
Am J Contact Dermat; 1999 Dec; 10(4):190-7. PubMed ID: 10594293
[TBL] [Abstract][Full Text] [Related]
23. Studies on poison ivy. In vitro lymphocyte transformation by urushiol-protein conjugates.
Dupuis G
Br J Dermatol; 1979 Dec; 101(6):617-24. PubMed ID: 161173
[TBL] [Abstract][Full Text] [Related]
24. In vitro studies of poison oak immunity. I. In vitro reaction of human lymphocytes to urushiol.
Byers VS; Epstein WL; Castagnoli N; Baer H
J Clin Invest; 1979 Nov; 64(5):1437-48. PubMed ID: 315414
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the contact sensitivity response to urushiol with anti-urushiol monoclonal antibody ALG 991.
Baldwin RW; Clegg JA; Curran AC; Austin EB; Khan T; Ma Y; Gunn B; Hudecz F; Byers VS; Lepoittevin JP; Price MR
Arch Dermatol Res; 1999 Dec; 291(12):652-8. PubMed ID: 10651166
[TBL] [Abstract][Full Text] [Related]
26. A murine model system for contact sensitization to poison oak or ivy urushiol components.
Dunn IS; Liberato DJ; Dennick RG; Castagnoli N; Byers VS
Cell Immunol; 1982 Apr; 68(2):377-88. PubMed ID: 6178516
[No Abstract] [Full Text] [Related]
27. Urushiol Patch Test Using the T.R.U.E. TEST System.
Kim Y; Longenecker A; ElSohly MA; Gul W; Hage RJ; Hamann CP; Marks JG
Dermatitis; 2018; 29(3):127-131. PubMed ID: 29762206
[TBL] [Abstract][Full Text] [Related]
28. Urushiol (poison ivy)-triggered suppressor T cell clone generated from peripheral blood.
Kalish RS; Morimoto C
J Clin Invest; 1988 Sep; 82(3):825-32. PubMed ID: 2458387
[TBL] [Abstract][Full Text] [Related]
29. Hyposensitization to urushiol among Japanese lacquer craftsmen: results of patch tests on students learning the art of lacquerware.
Kawai K; Nakagawa M; Kawai K; Liew FM; Yasuno H
Contact Dermatitis; 1991 Nov; 25(5):290-5. PubMed ID: 1839723
[TBL] [Abstract][Full Text] [Related]
30. Suppression of urushiol-induced delayed-type hypersensitivity responses in mice with serum IgG immunoglobulin from human hyposensitized donors.
Stampf JL; Castagnoli N; Epstein W; Baldwin RW; Byers V
J Invest Dermatol; 1990 Sep; 95(3):363-5. PubMed ID: 2384694
[TBL] [Abstract][Full Text] [Related]
31. [Contact allergy to Anacardiaceae. A review and case reports of poison ivy allergy in central Europe].
Ippen H
Derm Beruf Umwelt; 1983; 31(5):140-8. PubMed ID: 6227468
[TBL] [Abstract][Full Text] [Related]
32. Treatment of toxicodendron dermatitis (poison ivy and poison oak).
Guin JD
Skin Therapy Lett; 2001 Apr; 6(7):3-5. PubMed ID: 11376396
[TBL] [Abstract][Full Text] [Related]
33. Transcriptome profiling reveals Th2 bias and identifies endogenous itch mediators in poison ivy contact dermatitis.
Liu B; Tai Y; Liu B; Caceres AI; Yin C; Jordt SE
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184997
[TBL] [Abstract][Full Text] [Related]
34. Resorcinols and catechols: a clinical study of cross-sensitivity.
Knight TE; Boll P; Epstein WL; Prasad AK
Am J Contact Dermat; 1996 Sep; 7(3):138-45. PubMed ID: 8957327
[TBL] [Abstract][Full Text] [Related]
35. In situ changes in the relative abundance of human epidermal cytokine messenger RNA levels following exposure to the poison ivy/oak contact allergen urushiol.
Boehm KD; Yun JK; Strohl KP; Trefzer U; Häffner A; Elmets CA
Exp Dermatol; 1996 Jun; 5(3):150-60. PubMed ID: 8840155
[TBL] [Abstract][Full Text] [Related]
36. Analogues of poison ivy urushiol. Synthesis and biological activity of disubstituted n-alkylbenzenes.
ElSohly MA; Adawadkar PD; Benigni DA; Watson ES; Little TL
J Med Chem; 1986 May; 29(5):606-11. PubMed ID: 2939241
[TBL] [Abstract][Full Text] [Related]
37. Induction of persistent tolerance to urushiol in humans.
Epstein WL; Byers VS; Baer H
J Allergy Clin Immunol; 1981 Jul; 68(1):20-5. PubMed ID: 7240596
[TBL] [Abstract][Full Text] [Related]
38. There is an association between contact allergy to aluminium and persistent subcutaneous nodules in children undergoing hyposensitization therapy.
Netterlid E; Hindsén M; Björk J; Ekqvist S; Güner N; Henricson KA; Bruze M
Contact Dermatitis; 2009 Jan; 60(1):41-9. PubMed ID: 19125720
[TBL] [Abstract][Full Text] [Related]
39. Toxicodendron hyposensitization programs.
Watson ES
Clin Dermatol; 1986; 4(2):160-70. PubMed ID: 2941127
[No Abstract] [Full Text] [Related]
40. Quantitation and cloning of human urushiol specific peripheral blood T-cells: isolation of urushiol triggered suppressor T-cells.
Kalish RS; Morimoto C
J Invest Dermatol; 1989 Jan; 92(1):46-52. PubMed ID: 2521239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
